A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine

Author(s):
Bartolini, M.; Giamberardino, M.A.; Lisotto, C.; Martelletti, P.; Moscato, D.; Panascia, B.; Savi, L.; Pini, L.A.; Sances, G.; Santoro, P.; Zanchin, G.; Omboni, S.; Ferrari, M.D. (0000-0001-9691-9449); Brighina, F.; Fierro, B.
Published
2011
Publication type
Article / Letter to editor
MigraineFrovatriptanAlmotriptanPatient preference
Date issued
2011-06-30
Language
English
Is part of
JOURNAL OF HEADACHE AND PAIN (2011), Vol. 12, no. 3, p. 361-368
hdl
1887/118120
doi
10.1007/s10194-011-0325-5